3-[1-[3-(dimethylamino)propyl]indazol-3-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione;3-[2-[3-(dimethylamino)propyl]indazol-3-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione;methane;methyl 2-(1-methylindol-3-yl)-2-oxoacetate
C63H65N11O7 — CID 159237021
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[1-[3-(dimethylamino)propyl]indazol-3-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione;3-[2-[3-(dimethylamino)propyl]indazol-3-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione;methane;methyl 2-(1-methylindol-3-yl)-2-oxoacetate
3-[1-[3-(dimethylamino)propyl]indazol-3-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione;3-[2-[3-(dimethylamino)propyl]indazol-3-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione;methane;methyl 2-(1-methylindol-3-yl)-2-oxoacetate (PubChem CID 159237021) has the molecular formula C63H65N11O7 and a molecular weight of 1088.28 g/mol. Its IUPAC name is 3-[1-[3-(dimethylamino)propyl]indazol-3-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione;3-[2-[3-(dimethylamino)propyl]indazol-3-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione;methane;methyl 2-(1-methylindol-3-yl)-2-oxoacetate.
Molecular Properties
| Compound Name | 3-[1-[3-(dimethylamino)propyl]indazol-3-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione;3-[2-[3-(dimethylamino)propyl]indazol-3-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione;methane;methyl 2-(1-methylindol-3-yl)-2-oxoacetate |
|---|---|
| PubChem CID | 159237021 |
| Molecular Formula | C63H65N11O7 |
| Molecular Weight | 1088.28 g/mol |
| Exact Mass | 1087.51 |
| IUPAC Name | 3-[1-[3-(dimethylamino)propyl]indazol-3-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione;3-[2-[3-(dimethylamino)propyl]indazol-3-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione;methane;methyl 2-(1-methylindol-3-yl)-2-oxoacetate |
| SMILES | C.CN(C)CCCn1nc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2=O)c2ccccc21.CN(C)CCCn1nc2ccccc2c1C1=C(c2cn(C)c3ccccc23)C(=O)NC1=O.COC(=O)C(=O)c1cn(C)c2ccccc12 |
| InChI | InChI=1S/2C25H25N5O2.C12H11NO3.CH4/c1-28(2)13-8-14-30-23(17-10-4-6-11-19(17)27-30)22-21(24(31)26-25(22)32)18-15-29(3)20-12-7-5-9-16(18)20;1-28(2)13-8-14-30-20-12-7-5-10-17(20)23(27-30)22-21(24(31)26-25(22)32)18-15-29(3)19-11-6-4-9-16(18)19;1-13-7-9(11(14)12(15)16-2)8-5-3-4-6-10(8)13;/h2*4-7,9-12,15H,8,13-14H2,1-3H3,(H,26,31,32);3-7H,1-2H3;1H4 |
| InChIKey | KTPKOPXJSQFLOB-UHFFFAOYSA-N |
| XLogP | 8.26 |
| TPSA | 192.62 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 81 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1088.28 |
| LogP ≤ 5 | 8.26 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 16 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'diketo_group', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159237021 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.